# A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

> clinical trial · VERIFIED · 2026-08-20

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

- Company: National Cancer Institute (NCI)
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05675410

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.